{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:01:03Z","timestamp":1773486063892,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.biologicals.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:40:49Z","timestamp":1591231249000},"page":"41-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Third human challenge trial conference, Oxford, United Kingdom, February 6\u20137, 2020, a meeting report"],"prefix":"10.1016","volume":"66","author":[{"given":"Andrew J.","family":"Pollard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Baay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Neels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobana","family":"Balasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bejon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Berthels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Catchpole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Primus","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roma","family":"Chilengi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Emary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Frenck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Grimwade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanche","family":"Oguti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Openshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Osowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Ploin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meta","family":"Roestenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Selgelid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Wildfire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2020.04.004_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biologicals.2015.10.003","article-title":"Human challenge trials in vaccine development: Strasbourg, September 29 - October 1, 2014","volume":"44","author":"Sheets","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2020.04.004_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biologicals.2018.02.002","article-title":"Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017","volume":"61","author":"Baay","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2020.04.004_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/iai.56.1.161-167.1988","article-title":"Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques","volume":"56","author":"Levine","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.vaccine.2019.03.059","article-title":"Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): establishing a group A Streptococcus pharyngitis human infection study","volume":"37","author":"Osowicki","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.04.004_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00647-18","article-title":"A controlled human infection model of group A Streptococcus pharyngitis: which strain and why?","volume":"4","author":"Osowicki","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.biologicals.2020.04.004_bib7","article-title":"Vaccines for preventing typhoid fever","volume":"5","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biologicals.2020.04.004_bib8","unstructured":"WHO Expert Committee on Biological Standardization. Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines. Available from:."},{"key":"10.1016\/j.biologicals.2020.04.004_bib9","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/cix042","article-title":"Evaluation of the clinical and microbiological response to Salmonella paratyphi A infection in the first paratyphoid human challenge model","volume":"64","author":"Dobinson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.04.004_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz892","article-title":"Consensus report on Shigella controlled human infection model: conduct of studies","volume":"69","author":"Talaat","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.04.004_bib13","article-title":"Consensus report on Shigella controlled human infection model: clinical endpoints","volume":"69","author":"MacLennan","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"S596","DOI":"10.1093\/cid\/ciz909","article-title":"Consensus report on Shigella controlled human infection model: immunological assays","volume":"69","author":"Kaminski","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.04.004_bib15","author":"Reviewing Research"},{"key":"10.1016\/j.biologicals.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/infdis\/jiy275","article-title":"Establishing the production of male schistosoma mansoni cercariae for a controlled human infection model","volume":"218","author":"Janse","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.7326\/L18-0438","article-title":"Katayama syndrome without schistosoma mansoni eggs","volume":"170","author":"Langenberg","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.biologicals.2020.04.004_bib18","author":"Medical Research Council UK"},{"key":"10.1016\/j.biologicals.2020.04.004_bib19","author":"WHO Expert Committee on Biological Standardization"},{"key":"10.1016\/j.biologicals.2020.04.004_bib20","author":"Academy of Medical Sceinces"},{"key":"10.1016\/j.biologicals.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.12688\/wellcomeopenres.15469.1","article-title":"Factors influencing participation in controlled human infection models: a pooled analysis from six enteric fever studies","volume":"4","author":"Oguti","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.biologicals.2020.04.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1525\/jer.2013.8.4.1","article-title":"Consent and community engagement in diverse research contexts","volume":"8","year":"2013","journal-title":"J Empir Res Hum Res Ethics"},{"key":"10.1016\/j.biologicals.2020.04.004_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12936-015-0671-x","article-title":"Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya","volume":"14","author":"Hodgson","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.biologicals.2020.04.004_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001311","article-title":"Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand","volume":"5","author":"Anderson","year":"2011","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.biologicals.2020.04.004_bib25","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biologicals.2020.04.004_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01123-16","article-title":"Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against zika virus","volume":"7","author":"Swanstrom","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.biologicals.2020.04.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biologicals.2020.04.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002726","article-title":"Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua","volume":"16","author":"Gordon","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.biologicals.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3389\/fimmu.2019.02983","article-title":"Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.biologicals.2020.04.004_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev-immunol-051116-052206","article-title":"Protective and harmful immunity to RSV infection","volume":"35","author":"Openshaw","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.biologicals.2020.04.004_bib31","first-page":"56413","article-title":"Absorption of nasal and bronchial fluids: precision sampling of the human respiratory mucosa and laboratory processing of samples","volume":"131","author":"Thwaites","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.biologicals.2020.04.004_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10224","article-title":"RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection","volume":"6","author":"Jozwik","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.biologicals.2020.04.004_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.01.030","article-title":"Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women","volume":"21","author":"Kwatra","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.biologicals.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.vaccine.2017.04.013","article-title":"Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort","volume":"35","author":"Le Doare","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.04.004_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.biologicals.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fmicb.2017.00900","article-title":"Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre","volume":"8","author":"Gould","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.biologicals.2020.04.004_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2020.04.004_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.biologicals.2020.04.004_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"Sauerwein","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2020.04.004_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31549","article-title":"A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model","volume":"7","author":"Reuling","year":"2018","journal-title":"eLife"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:22Z","timestamp":1760922862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105620300440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"alternative-id":["S1045105620300440"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.04.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Third human challenge trial conference, Oxford, United Kingdom, February 6\u20137, 2020, a meeting report","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}